BKT140 (BL-8040) CXCR4 Research Workflows
2026-08-13
BKT140 (BL-8040) connects CXCR4 biology with practical assays for chemotaxis, tumor-cell survival, microenvironmental retention, and hematopoietic stem cell mobilization. This guide emphasizes assay design, formulation control, orthogonal validation, and troubleshooting across lymphoma, leukemia, multiple myeloma, and solid-tumor models.
Intravesical p21 mRNA-LNP Therapy in Bladder Cancer
2026-08-12
A 2026 FASEB Journal study developed lipid nanoparticles carrying chemically modified p21 mRNA for localized intravesical treatment of bladder cancer. The approach restored nuclear p21, suppressed tumor growth in an orthotopic mouse model, and limited systemic exposure, while also highlighting important translational questions about dosing, formulation, and long-term safety.
Hoechst 33342 for NECSO Cell Death Assays
2026-08-12
Use Hoechst 33342 to convert sodium-overload experiments into interpretable nuclear and cell-population readouts. This workflow distinguishes downstream chromatin and morphology changes from the mitochondrial energy failure that defines NECSO, while providing practical guidance for live-cell imaging, cell cycle analysis, and apoptosis-oriented validation.
AC Electrokinetic HRP Immobilization: Activity and Methods
2026-08-11
The reference study quantitatively evaluates horseradish peroxidase activity after AC dielectrophoretic immobilization on titanium nitride nanoelectrode arrays. Using Amplex Red and hydrogen peroxide fluorescence microscopy, the authors report detection down to 60 fg HRP and retain up to 45% of the activity expected for an ideal enzyme monolayer, supporting DEP-based enzyme biosensors while highlighting important limits on activity interpretation.
Prednisone Beyond Immunosuppression: Translational Strategy
2026-08-10
Prednisone is more than a familiar immunosuppressant: it is a controllable probe of lymphocyte state, cytokine signaling, and apoptosis. This thought-leadership guide shows how translational researchers can move from mechanism to reproducible assays, while using exposure discipline and metabolomics-inspired evidence design to strengthen interpretation.
(-)-Arctigenin: A Mechanistic Assay Roadmap
2026-08-09
(-)-Arctigenin offers a chemically defined way to interrogate NF-κB and MEK1 signaling, but its value in breast cancer research depends on separating pathway suppression from extracellular-vesicle biology. This article translates the miR-660/KLHL21 study into a rigorous assay strategy for testing mechanism without overstating evidence.
AZD1390: Reframing ATM Inhibition for G4 Stress
2026-08-08
AZD1390 offers translational researchers a potent ATM kinase inhibitor for connecting DNA double-strand break signaling, replication-associated G-quadruplex stress, and radiation response. By integrating REV1–DHX36 biology with preclinical radiosensitization evidence, this article outlines a disciplined strategy for mechanism-led cancer research without overstating what has been directly validated.
(5Z)-7-Oxozeaenol TAK1 Inhibitor Workflow
2026-08-07
Use (5Z)-7-Oxozeaenol to separate TAK1-dependent inflammatory signaling from broader metabolic-stress responses. This practical workflow combines concentration–time optimization, NF-κB and JNK/p38 MAPK readouts, COX-2 measurements, and a focused strategy for testing TAK1 involvement in the AMPK–SQSTM1/NRF2 feedback loop.
Merbromin as a Mixed-Type Inhibitor of SARS-CoV-2 3CLpro
2026-08-07
This study identifies merbromin as a potent, selective mixed-type inhibitor of the SARS-CoV-2 3-chymotrypsin-like protease (3CLpro), a key enzyme in viral replication. By leveraging high-throughput screening and enzymatic kinetics, the research advances understanding of selective protease targeting and lays a scaffold for rational antiviral inhibitor development.
HEY2 Regulates Mitochondrial Respiration in Cardiac Homeosta
2026-08-06
This study uncovers the role of HEY2 as a transcriptional repressor controlling mitochondrial oxidative metabolism in the heart. By mapping how HEY2 modulates gene expression and interacts with HDAC1, the work reveals a conserved regulatory module with implications for heart failure and energy metabolism research.
Ampicillin Sodium: Applied β-Lactam Antibiotic Workflows & T
2026-08-06
Ampicillin sodium is more than a foundational β-lactam antibiotic—it enables precision in bacterial selection, antibacterial activity assays, and recombinant protein workflows. Discover optimized protocols, troubleshooting strategies, and advanced applications that leverage its competitive inhibition of bacterial cell wall biosynthesis for robust, reproducible research.
KX2-361 Inhibits Botulinum Neurotoxin A in Neuronal Models
2026-08-05
This study demonstrates that KX2-361, a structural analog of tirbanibulin, can inhibit BoNT/A-mediated SNAP-25 cleavage in both pre- and post-intoxication cell models. Its blood-brain barrier penetration and activity within neurons position it as a promising therapeutic candidate for botulism, a field lacking effective post-exposure treatments.
Stat3 and NF-κB Synergy in Fyn Kinase-Induced Neurodegenerat
2026-08-05
This study demonstrates that Stat3 signaling mediates neurodegeneration and microglial activation downstream of Fyn kinase, using a zebrafish in vivo model. The findings offer mechanistic insight into the interplay between Stat3 and NF-κB pathways in dopaminergic neuronal loss, with implications for Parkinson’s disease research.
HATU-Driven Peptide Synthesis: Protocols, Applications, and
2026-08-04
HATU enables high-yield amide and ester formation, transforming peptide synthesis chemistry with rapid, selective couplings—even for challenging scaffolds. Discover practical workflow enhancements, advanced inhibitor design, and troubleshooting tactics that leverage APExBIO’s validated HATU for robust experimental success.
Cy5-UTP: Precision RNA Labeling for Advanced In Vitro Transc
2026-08-04
Cy5-UTP (Cyanine 5-uridine triphosphate) empowers researchers to synthesize highly fluorescent RNA probes for direct, multiplexed detection in demanding molecular assays. By streamlining in vitro transcription RNA labeling, it accelerates studies on RNA structure, trafficking, and complex cellular architectures.
464 records 9/31 page Previous Next First page 上5页 678910 下5页 Last page